Sharon E. Maynard

6.9k total citations · 1 hit paper
33 papers, 5.3k citations indexed

About

Sharon E. Maynard is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, Sharon E. Maynard has authored 33 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Obstetrics and Gynecology, 23 papers in Pediatrics, Perinatology and Child Health and 13 papers in Immunology. Recurrent topics in Sharon E. Maynard's work include Pregnancy and preeclampsia studies (25 papers), Birth, Development, and Health (21 papers) and Reproductive System and Pregnancy (10 papers). Sharon E. Maynard is often cited by papers focused on Pregnancy and preeclampsia studies (25 papers), Birth, Development, and Health (21 papers) and Reproductive System and Pregnancy (10 papers). Sharon E. Maynard collaborates with scholars based in United States. Sharon E. Maynard's co-authors include S. Ananth Karumanchi, Franklin H. Epstein, Vikas P. Sukhatme, Isaac E. Stillman, Frank W. Sellke, Susanta Mondal, Jianyi Li, Towia A. Libermann, James P. Morgan and Jaime R. Merchan and has published in prestigious journals such as Journal of Clinical Investigation, International Journal of Molecular Sciences and Kidney International.

In The Last Decade

Sharon E. Maynard

29 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

2003 3.1k citations Sharon E. Maynard, Jaime R. Merchan et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon E. Maynard United States	19	4.5k	3.2k	2.0k	631	477	33	5.3k
Kee-Hak Lim United States	8	3.4k 0.8×	2.4k 0.8×	1.5k 0.7×	542 0.9×	309 0.6×	8	4.0k
Stefan Verlohren Germany	36	4.8k 1.1×	3.8k 1.2×	1.9k 1.0×	300 0.5×	448 0.9×	103	5.6k
André Van Assche Belgium	14	3.4k 0.8×	2.5k 0.8×	792 0.4×	170 0.3×	634 1.3×	24	4.6k
Harald Zeisler Austria	27	3.0k 0.7×	2.3k 0.7×	1.2k 0.6×	250 0.4×	393 0.8×	104	3.9k
Haitao Yuan China	12	1.3k 0.3×	888 0.3×	741 0.4×	559 0.9×	165 0.3×	21	2.3k
Belinda Jim United States	22	885 0.2×	615 0.2×	341 0.2×	593 0.9×	238 0.5×	57	2.3k
Gloría Valdés Chile	24	1.0k 0.2×	587 0.2×	349 0.2×	116 0.2×	258 0.5×	62	1.8k
Donatella Colaizzo Italy	28	695 0.2×	404 0.1×	202 0.1×	283 0.4×	112 0.2×	84	2.5k
R M Bertina Netherlands	40	496 0.1×	272 0.1×	219 0.1×	492 0.8×	393 0.8×	105	7.8k
Jakob Lauritsen Denmark	25	274 0.1×	384 0.1×	404 0.2×	373 0.6×	389 0.8×	96	1.9k

Countries citing papers authored by Sharon E. Maynard

Since Specialization

Citations

This map shows the geographic impact of Sharon E. Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon E. Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon E. Maynard more than expected).

Fields of papers citing papers by Sharon E. Maynard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon E. Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon E. Maynard. The network helps show where Sharon E. Maynard may publish in the future.

Co-authorship network of co-authors of Sharon E. Maynard

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon E. Maynard. A scholar is included among the top collaborators of Sharon E. Maynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon E. Maynard. Sharon E. Maynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maynard, Sharon E., et al.. (2024). Donor-Derived AA Amyloidosis in a Kidney Allograft. Journal of the American Society of Nephrology. 35(10S).

Maynard, Sharon E., Amy N. Sussman, Oliver Lenz, et al.. (2021). Assessing Nephrology Fellows’ Skills in Communicating About Kidney Replacement Therapy and Kidney Biopsy: A Multicenter Clinical Simulation Study on Breaking Bad News. American Journal of Kidney Diseases. 78(4). 541–549. 7 indexed citations

Maynard, Sharon E., et al.. (2013). Gestational angiogenic biomarker patterns in high risk preeclampsia groups. American Journal of Obstetrics and Gynecology. 209(1). 53.e1–53.e9. 42 indexed citations

Simas, Tiffany A. Moore, et al.. (2013). Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women. The Journal of Maternal-Fetal & Neonatal Medicine. 27(10). 1038–1048. 35 indexed citations

Young, Heather A., et al.. (2012). Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine. 25(12). 2651–2657. 53 indexed citations

Maynard, Sharon E., et al.. (2011). Acute kidney injury in pregnancy: the thrombotic microangiopathies. Journal of Nephrology. 24(5). 554–563. 34 indexed citations

Maynard, Sharon E. & S. Ananth Karumanchi. (2011). Angiogenic Factors and Preeclampsia. Seminars in Nephrology. 31(1). 33–46. 349 indexed citations

Maynard, Sharon E., et al.. (2010). Soluble Endoglin for the Prediction of Preeclampsia in a High Risk Cohort. Hypertension in Pregnancy. 29(3). 330–341. 24 indexed citations

Janakiraman, Vanitha, Marie G. Gantz, Sharon E. Maynard, & Ayman El-Mohandes. (2009). Association of cotinine levels and preeclampsia among African-American women. Nicotine & Tobacco Research. 11(6). 679–684. 9 indexed citations

10.

Maynard, Sharon E. & Ravi Thadhani. (2009). Pregnancy and the Kidney. Journal of the American Society of Nephrology. 20(1). 14–22. 107 indexed citations

11.

Nguyen, Mai T., Sharon E. Maynard, & Paul L. Kimmel. (2009). Misapplications of Commonly Used Kidney Equations. Clinical Journal of the American Society of Nephrology. 4(3). 528–534. 39 indexed citations

12.

Maynard, Sharon E., et al.. (2008). Circulating angiogenic factors in singleton vs multiple-gestation pregnancies. American Journal of Obstetrics and Gynecology. 198(2). 200.e1–200.e7. 39 indexed citations

13.

Levine, Richard J., Chun Sing Lam, Cong Qian, et al.. (2007). Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia. Obstetrical & Gynecological Survey. 62(2). 82–83. 177 indexed citations

14.

Simas, Tiffany A. Moore, et al.. (2007). Angiogenic factors for the prediction of preeclampsia in high-risk women. American Journal of Obstetrics and Gynecology. 197(3). 244.e1–244.e8. 155 indexed citations

15.

Maynard, Sharon E., Franklin H. Epstein, & S. Ananth Karumanchi. (2007). Preeclampsia and Angiogenic Imbalance. Annual Review of Medicine. 59(1). 61–78. 246 indexed citations

16.

Levine, Richard J., Cong Qian, Sharon E. Maynard, et al.. (2006). Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. American Journal of Obstetrics and Gynecology. 194(4). 1034–1041. 99 indexed citations

17.

Karumanchi, S. Ananth, Sharon E. Maynard, Isaac E. Stillman, Franklin H. Epstein, & Vikas P. Sukhatme. (2005). Preeclampsia: A renal perspective. Kidney International. 67(6). 2101–2113. 223 indexed citations

18.

Maynard, Sharon E., Shivalingappa Venkatesha, Ravi Thadhani, & S. Ananth Karumanchi. (2005). Soluble Fms-like Tyrosine Kinase 1 and Endothelial Dysfunction in the Pathogenesis of Preeclampsia. Pediatric Research. 57(5 Part 2). 1R–7R. 192 indexed citations

19.

Maynard, Sharon E., Jaime R. Merchan, Kee-Hak Lim, et al.. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigation. 111(5). 649–658. 3135 indexed citations breakdown →

20.

Maynard, Sharon E., Jeff Whittle, Lakshmipathi Chelluri, & Robert M. Arnold. (2003). Quality of life and dialysis decisions in critically ill patients with acute renal failure. Intensive Care Medicine. 29(9). 1589–1593. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact